Aspirin moderates the association between cardiovascular risk, brain white matter hyperintensity total lesion volume and processing speed in normal ageing

Research output: Contribution to journalArticle

Abstract

Objectives Cardiovascular risk is associated with cognitive decline and this effect is attributed to brain pathology, including white matter hyperintensity (WMH) burden. Low-dose aspirin is frequently recommended for reducing vascular events. We investigated the effect of taking aspirin on the association between cardiovascular risk, WMH burden and cognitive function. Study design The study sample was drawn from 318 dementia-free adults aged 67-71 years. Brain magnetic resonance imaging (MRI) scans were acquired from 239 participants. Main outcome measures WMH total lesion volumes (TLV) were extracted using the automated lesion segmentation algorithm. We measured cardiovascular risk by calculating ASSIGN score. Cognitive ability was measured using a test of processing speed. We developed structural equation models to test our hypothesis. Results Sixty-eight participants (47.1% male, mean age = 68.8 years) reported that they took aspirin. The demographic measures did not differ significantly by aspirin use. Among aspirin users, there was a strong negative association between WMH TLV and cognition (β = -0.43, p-value < 0.001), while in non-users of aspirin the only significant predictor of poorer cognition was cardiovascular risk (β= -0.17, p-value = 0.001). Conclusions Aspirin use moderates the negative effect of WMH burden on cognition. Considering WMH burden in addition to cardiovascular risk could improve the prediction of cognitive decline in older adults with aspirin use.
Original languageEnglish
Pages (from-to)49-53
Number of pages5
JournalMaturitas
Volume133
Early online date7 Jan 2020
DOIs
Publication statusE-pub ahead of print - 7 Jan 2020

Fingerprint

Aspirin
Brain
Aging of materials
Cognition
Processing
Aptitude
Structural Models
Pathology
Magnetic resonance
White Matter
Blood Vessels
Dementia
Magnetic Resonance Imaging
Demography
Imaging techniques

Keywords

  • aspirin
  • cardiovascular risk
  • brain white matter hyperintensity
  • cognition
  • older adults
  • Aspirin
  • Brain white matter hyperintensity
  • Cardiovascular risk
  • Cognition
  • Older adults

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Obstetrics and Gynaecology

Cite this

@article{8546f1fbfca54dffa2625d837f497f04,
title = "Aspirin moderates the association between cardiovascular risk, brain white matter hyperintensity total lesion volume and processing speed in normal ageing",
abstract = "Objectives Cardiovascular risk is associated with cognitive decline and this effect is attributed to brain pathology, including white matter hyperintensity (WMH) burden. Low-dose aspirin is frequently recommended for reducing vascular events. We investigated the effect of taking aspirin on the association between cardiovascular risk, WMH burden and cognitive function. Study design The study sample was drawn from 318 dementia-free adults aged 67-71 years. Brain magnetic resonance imaging (MRI) scans were acquired from 239 participants. Main outcome measures WMH total lesion volumes (TLV) were extracted using the automated lesion segmentation algorithm. We measured cardiovascular risk by calculating ASSIGN score. Cognitive ability was measured using a test of processing speed. We developed structural equation models to test our hypothesis. Results Sixty-eight participants (47.1{\%} male, mean age = 68.8 years) reported that they took aspirin. The demographic measures did not differ significantly by aspirin use. Among aspirin users, there was a strong negative association between WMH TLV and cognition (β = -0.43, p-value < 0.001), while in non-users of aspirin the only significant predictor of poorer cognition was cardiovascular risk (β= -0.17, p-value = 0.001). Conclusions Aspirin use moderates the negative effect of WMH burden on cognition. Considering WMH burden in addition to cardiovascular risk could improve the prediction of cognitive decline in older adults with aspirin use.",
keywords = "aspirin, cardiovascular risk, brain white matter hyperintensity, cognition, older adults, Aspirin, Brain white matter hyperintensity, Cardiovascular risk, Cognition, Older adults",
author = "Mina Khezrian and Waymont, {Jennifer M J} and Myint, {Phyo K} and McNeil, {Christopher J} and Lawrence Whalley and Roger Staff and Murray, {Alison D}",
note = "ABC1936 was funded (1999-2009) by the Biotechnology and Biological Sciences Research Council, Scottish Health Department, Wellcome Trust, Medical Research Council, Alzheimer Research UK, Alzheimer Society and University of Aberdeen Development Trust. This work was supported by the Elphinstone Scholarship, Roland Sutton Academic Trust, the Morningfield Association and the Rabin Ezra Scholarship Trust, which provides salary cost and consumables to MK.",
year = "2020",
month = "1",
day = "7",
doi = "10.1016/j.maturitas.2020.01.001",
language = "English",
volume = "133",
pages = "49--53",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Aspirin moderates the association between cardiovascular risk, brain white matter hyperintensity total lesion volume and processing speed in normal ageing

AU - Khezrian, Mina

AU - Waymont, Jennifer M J

AU - Myint, Phyo K

AU - McNeil, Christopher J

AU - Whalley, Lawrence

AU - Staff, Roger

AU - Murray, Alison D

N1 - ABC1936 was funded (1999-2009) by the Biotechnology and Biological Sciences Research Council, Scottish Health Department, Wellcome Trust, Medical Research Council, Alzheimer Research UK, Alzheimer Society and University of Aberdeen Development Trust. This work was supported by the Elphinstone Scholarship, Roland Sutton Academic Trust, the Morningfield Association and the Rabin Ezra Scholarship Trust, which provides salary cost and consumables to MK.

PY - 2020/1/7

Y1 - 2020/1/7

N2 - Objectives Cardiovascular risk is associated with cognitive decline and this effect is attributed to brain pathology, including white matter hyperintensity (WMH) burden. Low-dose aspirin is frequently recommended for reducing vascular events. We investigated the effect of taking aspirin on the association between cardiovascular risk, WMH burden and cognitive function. Study design The study sample was drawn from 318 dementia-free adults aged 67-71 years. Brain magnetic resonance imaging (MRI) scans were acquired from 239 participants. Main outcome measures WMH total lesion volumes (TLV) were extracted using the automated lesion segmentation algorithm. We measured cardiovascular risk by calculating ASSIGN score. Cognitive ability was measured using a test of processing speed. We developed structural equation models to test our hypothesis. Results Sixty-eight participants (47.1% male, mean age = 68.8 years) reported that they took aspirin. The demographic measures did not differ significantly by aspirin use. Among aspirin users, there was a strong negative association between WMH TLV and cognition (β = -0.43, p-value < 0.001), while in non-users of aspirin the only significant predictor of poorer cognition was cardiovascular risk (β= -0.17, p-value = 0.001). Conclusions Aspirin use moderates the negative effect of WMH burden on cognition. Considering WMH burden in addition to cardiovascular risk could improve the prediction of cognitive decline in older adults with aspirin use.

AB - Objectives Cardiovascular risk is associated with cognitive decline and this effect is attributed to brain pathology, including white matter hyperintensity (WMH) burden. Low-dose aspirin is frequently recommended for reducing vascular events. We investigated the effect of taking aspirin on the association between cardiovascular risk, WMH burden and cognitive function. Study design The study sample was drawn from 318 dementia-free adults aged 67-71 years. Brain magnetic resonance imaging (MRI) scans were acquired from 239 participants. Main outcome measures WMH total lesion volumes (TLV) were extracted using the automated lesion segmentation algorithm. We measured cardiovascular risk by calculating ASSIGN score. Cognitive ability was measured using a test of processing speed. We developed structural equation models to test our hypothesis. Results Sixty-eight participants (47.1% male, mean age = 68.8 years) reported that they took aspirin. The demographic measures did not differ significantly by aspirin use. Among aspirin users, there was a strong negative association between WMH TLV and cognition (β = -0.43, p-value < 0.001), while in non-users of aspirin the only significant predictor of poorer cognition was cardiovascular risk (β= -0.17, p-value = 0.001). Conclusions Aspirin use moderates the negative effect of WMH burden on cognition. Considering WMH burden in addition to cardiovascular risk could improve the prediction of cognitive decline in older adults with aspirin use.

KW - aspirin

KW - cardiovascular risk

KW - brain white matter hyperintensity

KW - cognition

KW - older adults

KW - Aspirin

KW - Brain white matter hyperintensity

KW - Cardiovascular risk

KW - Cognition

KW - Older adults

UR - http://www.scopus.com/inward/record.url?scp=85077652926&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2020.01.001

DO - 10.1016/j.maturitas.2020.01.001

M3 - Article

VL - 133

SP - 49

EP - 53

JO - Maturitas

JF - Maturitas

SN - 0378-5122

ER -